Telemedicine and Pharmacy: Expanding Access to Medication Therapy Management Services
DOI:
https://doi.org/10.61841/wmt7g192Keywords:
Telemedicine, Pharmacy, Medication Therapy Management, Access ExpansionAbstract
The integration of telemedicine into pharmacy practice has ushered in a transformative era for healthcare, particularly in the realm of medication therapy management (MTM) services. This research paper explores the profound impact of telemedicine on expanding access to MTM services, providing an essential platform for the optimal management of medication regimens. Drawing from a comprehensive literature review, this paper illuminates the significance of MTM in healthcare, highlighting the crucial role it plays in patient outcomes and medication adherence. We investigate the evolving landscape of telemedicine and its application in pharmacy, shedding light on the numerous benefits and challenges inherent in this integration. The paper delves into the perspectives of both patients and pharmacists, revealing the tangible advantages telemedicine-based MTM services offer in terms of convenience, accessibility, and improved patient outcomes. It also addresses the economic and regulatory factors influencing the adoption of telemedicine in pharmacy practice. However, this research does not shy away from the ethical, legal, and technological challenges that telemedicine and pharmacy must overcome, along with potential limitations of these services. In conclusion, this research paper underscores the potential of telemedicine to enhance access to MTM services, providing valuable insights into the evolving healthcare landscape and offering guidance for future research, policy, and practice considerations in the telemedicine-pharmacy nexus. As healthcare continues to evolve, telemedicine and pharmacy stand as essential partners in the pursuit of better medication management and improved patient care.
Downloads
References
1. Poudel and L. Nissen, “Telepharmacy: a pharmacist’s perspective on the clinical benefits and challenges,” Integrated Pharmacy Research and Practice, vol. Volume 5, pp. 75–82, Oct. 2016, doi: 10.2147/iprp.s101685.
2. R. JM, “Assessment of Contaminated Soil with Some Heavy Metals in Selected Auto Repair Shops in Katsina, North Western, Nigeria,” Open Access Journal of Waste Management & Xenobiotics, vol. 1, no. 2, 2018, doi:10.23880/oajwx-16000113.
3. “TELEPHARMACY RULES AND STATUTES: A 50-STATE SURVEY,” American Journal of Medical Research, vol. 5, no. 2, p. 7, 2018, doi: 10.22381/ajmr5220181.
4. R. Philips et al., “Cost savings associated with an outpatient otolaryngology telemedicine clinic,” Laryngoscope Investigative Otolaryngology, vol. 4, no. 2, pp. 234–240, Jan. 2019, doi: 10.1002/lio2.244.
5. M. McLaughlin et al., “Effects on Patient Care Caused by Drug Shortages: A Survey,” Journal of Managed Care Pharmacy, vol. 19, no. 9, pp. 783–788, Nov. 2013, doi: 10.18553/jmcp.2013.19.9.783.
6. W. Mariani and P. M. Pêgo-Fernandes, “Telemedicine: a technological revolution,” Sao Paulo Medical Journal, vol. 130, no. 5, pp. 277–278, 2012, doi: 10.1590/s1516-31802012000500001.
7. E. Sukkar, “Greeks feel effects of drug shortages caused by austerity measures,” BMJ, vol. 344, no. 21, pp. e3589–e3589, May 2012, doi: 10.1136/bmj.e3589.
8. P. O’Hanley, “Telephone Triage: The Quiet Revolution in Canada,” Telemedicine Journal and e-Health, vol. 10, no. 1, pp. 109–111, Mar. 2004, doi: 10.1089/153056204773644652. 9. P. Eastman, “Oncology Drug Shortages Worsening, Threatening Patient Care,” Oncology Times, vol. 33, no. 15, pp. 14–15, Aug. 2011, doi: 10.1097/01.cot.0000403835.67731.c7.
10. O. E. Williams, S. Elghenzai, C. Subbe, J. C. Wyatt, and J. Williams, “The use of telemedicine to enhance secondary care: some lessons from the front line,” Future Hospital Journal, vol. 4, no. 2, pp. 109–114, Jun. 2017, doi:10.7861/futurehosp.4-2-109.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
